SecFilingDex

VOLITIONRX LTD

40 SEC EDGAR filings indexed (CIK 0000093314) across 11 form types.

Filing profile

VOLITIONRX LTD (VNRX) has 40 SEC filings indexed on SecFilingDex, across 11 form types filed over roughly 1 year, from April 4, 2025 to August 24, 2026. The filer is classified under In Vitro & In Vivo Diagnostic Substances (SIC 2835).

Its most frequent disclosure is the 8-K (Material event) with 8 filings — Current report announcing a material event, such as an acquisition, executive change, or earnings release. 31 of these filings were disclosed in the twelve months to August 24, 2026. 4 of the 40 are amendments (a corrected or updated version of an earlier filing).

Disclosure mix

  • 88-KMaterial event · event-driven
  • 8Form 4Insider transaction · within 2 business days of transaction
  • 7424B5Prospectus supplement · event-driven
  • 510-QQuarterly report · quarterly
  • 3DEF 14AProxy statement · annual (pre-meeting)
  • 3PRE 14ASEC filing
  • 28-K/AMaterial event · event-driven
  • 110-K/AAnnual report · annual
  • 110-KAnnual report · annual
  • 110-Q/AQuarterly report · quarterly
  • 1S-1IPO registration · event-driven (pre-ipo)

Profile derived from 40 indexed filings; every figure traces to the filing records above, each linking back to its original SEC EDGAR document. Filing counts reflect SecFilingDex's current index, not the filer's complete EDGAR history.

All filings

Authoritative source

https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=93314&type=&dateb=&owner=include&count=40

SecFilingDex republishes EDGAR data with provenance. EDGAR is authoritative; this page reflects the most recent index pull.

Disclaimer: SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page is investment, legal, or tax advice.